Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Burning Stone Medicine (BNR.US) announced that the ADS ratio change will take effect on May 15
Glonghui, May 14, 丨 Burning Stone Medicine (BNR.US) announced today that the change in the ADS exchange ratio will take effect on May 15. From the previous 1 ADS equivalent to 1 Class A common share, the change was changed from 1 ADS equal to 10 Class A common shares. This change will not change Burning Stone Medical's common stock. Due to changes in the ADS ratio, the ADS price is expected to rise proportionately, although the company cannot guarantee that the ADS price after the ADS ratio changes will be equal to or greater than ten times the ADS price before the change.
Burning Rock Biotech Announces Reverse ADS Split
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
For Burning Rock's ADS holders, the ADS Ratio Change will have the same effect as a one-for-ten reverse ADS split.
Burning Rock Biotech Files 2023 Annual Report
Burning Stone Medicine (BNR.US) Announces ADS Ratio Changes
On April 27, 2024 | On April 26, 2024, Burning Stone Medicine (NASDAQ: BNR and London Stock Exchange: BNR, or Burning Rock), a company focusing on the application of next-generation sequencing (NGS) technology in the field of precision oncology announced that it will change the ratio of American Depositary Shares (ADS) to Class A common shares from a ratio representing 1 ADS share to a ratio of Class A common shares (“ADS ratio change”) with 1 share representing 10 Class A common shares . ADS ratio change forecast
Burning Rock Biotech To Carry Out 1-for-10 Reverse Stock Split On May 15th, 2024
April 27th - $Burning Rock Biotech(BNR.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 15th, 2024.$Burning Rock Bi
Burning Rock Biotech To Adjust ADS To Ordinary Share Ratio Effective May 15
BNR will change the ratio of its American depositary shares (the "ADSs") to Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing ten (10) Cl
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90
02:01 AM EDT, 04/02/2024 (MT Newswires) -- Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90
Q4 2023 Burning Rock Biotech Ltd Earnings Call
Burning Rock Biotech GAAP EPS of -$0.22, Revenue of $17.1M
Burning Rock Biotech's 2023 Financial Dynamics
Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reporte
Burning Rock Biotech 4Q Rev CNY121.1M >BNR
Burning Rock Biotech 4Q Rev CNY121.1M >BNR
Earnings Flash (BNR) BURNING ROCK BIOTECH LIMITED Posts Q4 Revenue RMB121.1M
05:18 PM EDT, 03/28/2024 (MT Newswires) -- Earnings Flash (BNR) BURNING ROCK BIOTECH LIMITED Posts Q4 Revenue RMB121.1M
Press Release: Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results GUANGZHOU, China, March 28, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the "Company" or
Express News | Burning Stone Medical issued a statement on the “Internet Transmission of Burning Stone Medicine Employee Report Letter”
Express News | According to the Internet, Burnstone Medical employees reported the company's genetic testing cash rebate. The company claimed that the employees involved were unaware of this and did not respond
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersCardiff Oncology (NASDAQ:CRDF) shares moved upwards by 28.6% to $2.27 during Thursday's after-market session. The company's market cap stands at $101.4 million. As per the press release, Q4 ear
No Data